Integrating case counts with genomic sequences quantifies real-time transmission advantages of viral variants.

If you want to hit your target, you need three things: a gun, a target and a method by which to hit that target with that gun ...

Alchemab Therapeutics in Cambridge has secured £25 million ($34m) additional Series A funding from the British Business Bank.

Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.

A team of scientists from Switzerland and France propose that animals learned to communicate at this rhythm hundreds of ...

Math classrooms shifted over time to the discovery model. Not suddenly, and not without good intentions. There was a ...

Clinical-stage biotech Alchemab Therapeutics has extended its series A financing with a £25 million (USD $34 million) investment from the British Business Bank - the Bank's largest investment in a ...

Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...

The neo-noir from writer-director Michele Fiascaris, screening at Karlovy Vary, is led by Dudley O'Shaughnessy and also ...

Phylo-Plex, a new computational method, has been developed by Wellcome Sanger Institute scientists and their collaborators to ...

Ever wondered where your plastics end up? A PET bottle can be washed, shredded, melted and given a second life. But most ...

What if time doesn't actually exist until something changes? Scientists at the University of Birmingham created a tiny "mini ...